Presentation of Probi’s Q3 report 2022
Probi’s report for the third quarter 2022 will be published on Friday, 21 October at 8.00 a.m. CET.
In conjunction with this, analysts, investors and media are invited to an audiocast telephone conference on the same day at 10.00 a.m., where CEO Tom Rönnlund and CFO Henrik Lundkvist will present and comment on the report. The presentation and presentation material can be obtained via www.probi.com or https://tv.streamfabriken.com/probi-q3-2022
The presentation can also be followed via a telephone conference on the following telephone number:
Sweden: +46 8 56 64 27 06
UK: +44 33 33 00 92 66
US: +1 64 67 22 49 56
After the presentation, conference participants will be able to ask questions. Questions can also be asked via the audiocast.
An on-demand version of the presentation will be available at the address given above following the presentation.
For further information, please contact:
Henrik Lundkvist, CFO, Probi, Phone +46 46 286 89 41, E-mail: [email protected]
ABOUT PROBI
Probi® is a global Group that focuses exclusively on research, manufacturing and delivery of probiotics in dietary supplements and food. The company has expertise in managing live bacteria from research through all stages of the manufacturing process and is dedicated to making the health-promoting benefits of probiotics available to people around the world. Since the company was founded in 1991 at Lund University in Sweden, Probi has expanded its operations to more than 40 markets and holds more than 400 patents worldwide. Probi had sales of SEK 658 m in 2021. Probi's shares are listed on Nasdaq Stockholm, Mid-cap, and there were around 3,800 shareholders on December 31, 2021.
